ITGR · XBRL financial data
Integer Holdings financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (ITGR's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 29, 2024 | Jun 28, 2024 | Sep 27, 2024 | Dec 31, 2024 | Mar 28, 2025 | Jun 27, 2025 | Sep 26, 2025 | Dec 31, 2025 | Apr 3, 2026 | Jul 3, 2026 | Oct 2, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 413* | 415 | 436 | 431 | 449* | 437 | 476 | 468 | 472* | 440 | 464 | 450 |
| Cost of goods and services sold | 303* | 305 | 317 | 315 | 333* | 317 | 347 | 342 | 347* | 330 | 351 | 348 |
| Gross profit | 110* | 110 | 119 | 117 | 117* | 120 | 129 | 126 | 125* | 110 | 113 | 102 |
| Selling, general and administrative | 46* | 47 | 47 | 45 | 47* | 51 | 53 | 50 | 57* | 59 | 58 | 54 |
| Total operating expenses | 67* | 71 | 64 | 59 | 60* | 71 | 70 | 70 | 69* | 78 | 78 | 73 |
| Operating income (loss) | 44* | 39 | 55 | 58 | 57* | 50 | 59 | 56 | 56* | 32 | 35 | 28 |
| Interest expense | 13* | 15 | 15 | 15 | 13* | 15 | 10 | 9 | 9* | 10 | 10 | 10 |
| Other income (expense) | 1* | (1) | 0 | (1) | (2)* | (48) | (4) | (1) | (0)* | (0) | (1) | (1) |
| Income tax expense (benefit) | 3* | 4 | 9 | 7 | 6* | 9 | 9 | 6 | (2)* | 4 | (0) | 3 |
| Net income (loss) | 26* | 21 | 31 | 35 | 33* | (22) | 37 | 40 | 49* | 17 | 24 | 15 |
| Earnings per share, basic USD per share | 0.79* | 0.61 | 0.93 | 1.05 | 0.97* | (0.66) | 1.06 | 1.13 | 1.39* | 0.48 | 0.69 | 0.44 |
| Earnings per share, diluted USD per share | 0.78* | 0.59 | 0.88 | 0.99 | 0.90* | (0.66) | 1.04 | 1.11 | 1.31* | 0.48 | 0.69 | 0.43 |
| Weighted average shares, basic millions of shares | 33* | 33 | 34 | 34 | 34* | 34 | 35 | 35 | 35* | 34 | 34 | 34 |
| Weighted average shares, diluted millions of shares | 34* | 35 | 36 | 36 | 36* | 34 | 36 | 36 | 37* | 34 | 34 | 35 |
Balance sheet
CSVFiscal quarters (ITGR's year ends in late December)
Cash flows
CSVFiscal quarters (ITGR's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 29, 2024 | Jun 28, 2024 | Sep 27, 2024 | Dec 31, 2024 | Mar 28, 2025 | Jun 27, 2025 | Sep 26, 2025 | Dec 31, 2025 | Apr 3, 2026 | Jul 3, 2026 | Oct 2, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 26* | 21 | 31 | 35 | 33* | (22) | 37 | 40 | 49* | 17 | 24 | 15 |
| Stock-based compensation | 6* | 7 | 6* | 6* | 6* | 7 | 6* | 5* | 6* | 7 | 5* | 5* |
| Depreciation and amortization | 26* | 26 | 27* | 29* | 29* | 30 | 32* | 33* | 36* | 35 | 35* | 34* |
| Net cash from operating activities | 56* | 23 | 47* | 72* | 63* | 31 | 44* | 66* | 55* | 25 | 60* | 37* |
| Purchases of property and equipment | 37* | 29 | 31* | 26* | 19* | 25 | 19* | 19* | 27* | 24 | 23* | 21* |
| Net cash from investing activities | (81)* | (168) | (31)* | (26)* | 30* | (197) | (18)* | (20)* | (35)* | (38) | (23)* | (21)* |
| Share repurchases | year only | — | — | — | year only | 0 | 0* | 0* | 50* | 50 | 0* | 0* |
| Proceeds from long-term debt | 0* | 0 | 0* | 0* | 0* | 978 | 0* | 0* | 0* | 0 | 0* | 0* |
| Repayments of long-term debt | 0* | 0 | 0* | 0* | 0* | 614 | 44* | 0* | 10* | 0 | 0* | 0* |
| Net cash from financing activities | 18* | 163 | (25)* | (43)* | (82)* | 152 | (36)* | (11)* | (62)* | 4 | (24)* | (22)* |
| Net change in cash | (8)* | 18 | (8)* | 1* | 11* | (15) | (9)* | 36* | (42)* | (9) | 13* | (7)* |
Compare with peers
SIC 3845 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3845 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Integer Holdings | 14 | 450 | 37* | 34.0M | — | 10-QOct 2, 2026 |
| TransMedics Group | 491 | 190 | 17* | 34.7M | — | 10-QJun 30, 2026 |
| Masimo | 125 | 404 | 45 | 52.4M | — | 10-QApr 4, 2026 |
| Inspire Medical Systems | 191 | 207 | 46* | 29.0M | — | 10-QSep 30, 2026 |
| iRhythm Holdings | 247 | 224 | 51* | 33.0M | — | 10-QJun 30, 2026 |
| Merit Medical Systems | 504 | 416 | 65* | 59.9M | — | 10-QSep 30, 2026 |
| Icu Medical | 298 | 552 | 80* | 25.0M | — | 10-QJun 30, 2026 |
| PROCEPT BioRobotics | 228 | 94 | (19)* | 57.3M | 11.8 quarters | 10-QJun 30, 2026 |
| Dentsply Sirona | 239 | 898 | 99* | 199.4M | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.